News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
330,372 Results
Type
Article (12456)
Company Profile (100)
Press Release (317809)
Multimedia
Podcasts (40)
Webinars (10)
Section
Business (116320)
Career Advice (755)
Deals (17264)
Drug Delivery (79)
Drug Development (25373)
Employer Resources (39)
FDA (5460)
Job Trends (7768)
News (153004)
Policy (12617)
Tag
2025 Best Places to Work (9)
2026 Best Places to Work (11)
2027 BioCapital Standard (4)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (5)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (2)
2027 Pharm Country Standard (5)
40 Under 40 (2)
Academia (1369)
Academic (1)
Accelerated approval (29)
ADA (23)
Adcomms (12)
Allergies (82)
Alliances (30867)
ALS (94)
Alzheimer's disease (821)
Antibody-drug conjugate (ADC) (285)
Approvals (5789)
Artificial intelligence (720)
ASCO (108)
Autoimmune disease (208)
Automation (50)
Bankruptcy (140)
Belgium (27)
Best Places to Work (6598)
BIO (36)
Biologics (53)
BIOSECURE Act (12)
Biosimilars (120)
BioSpace Insights (59)
Biotechnology (67)
Bispecific (31)
Bladder cancer (62)
Brain cancer (29)
Breast cancer (351)
Cancer (3170)
Cardiovascular disease (226)
Career advice (671)
Career pathing (29)
CAR-T (135)
CDC (51)
CDMO (107)
Celiac Disease (2)
Cell-line development (1)
Cell therapy (419)
Cervical cancer (22)
Clinical research (22759)
Collaboration (1762)
Commercialization (36)
Company closure (5)
Compensation (1169)
Complete response letters (24)
COVID-19 (947)
CRISPR (65)
CRO (8)
C-suite (837)
Cystic fibrosis (65)
Data (4166)
Decentralized trials (2)
Denatured (13)
Depression (79)
Dermatology (83)
Diabetes (283)
Diagnostics (4146)
Digital health (41)
Diversity (6)
Diversity, equity & inclusion (12)
Drug discovery (442)
Drug pricing (117)
Drug shortages (8)
Duchenne muscular dystrophy (97)
Earnings (38163)
Editorial (35)
Employer branding (3)
Employer resources (41)
ESMO (151)
Events (45533)
Executive appointments (746)
Eye disease (8)
FDA (7372)
Fibrodysplasia Ossificans Progressiva (9)
Fragile X (3)
Friedreich's ataxia (9)
Frontotemporal dementia (11)
Funding (1076)
Gene editing (103)
Generative AI (67)
Gene therapy (306)
GLP-1 (441)
Government (2601)
Grass and pollen (5)
Guidances (259)
Healthcare (10743)
Hematology (97)
HIV (63)
Huntington's disease (33)
IgA nephropathy (30)
Immunology and inflammation (89)
Immuno-oncology (68)
Indications (109)
Infectious disease (1110)
Inflammatory bowel disease (127)
Inflation Reduction Act (12)
Influenza (51)
Intellectual property (122)
Interviews (116)
IPO (7657)
IRA (37)
Job creations (1340)
Job search strategy (556)
JPM (16)
Kidney cancer (6)
Kidney disease (60)
Labor market (81)
Layoffs (199)
Leadership (16)
Legal (2490)
Licensing (69)
Liver cancer (26)
Longevity (26)
Lung cancer (438)
Lung diease (10)
Lymphoma (245)
Machine learning (57)
Management (14)
Manufacturing (909)
Marketing (14)
MASH (73)
Medical affairs (3)
Medical device (5582)
Medtech (5694)
Melanoma (63)
Mergers & acquisitions (10436)
Metabolic disorders (656)
Middle East (2)
mRNA (100)
Multiple sclerosis (69)
Multispecific (3)
NASH (3)
Netherlands (23)
Neurodegenerative disease (217)
Neuropsychiatric disorders (28)
Neuroscience (1607)
NextGen: Class of 2026 (3781)
Non-profit (3017)
Now hiring (38)
Obesity (256)
Opinion (139)
Ovarian cancer (91)
Pain (96)
Pancreatic cancer (129)
Parkinson's disease (191)
Partnered (28)
Patents (240)
Patient advocacy (4)
Patient recruitment (319)
Patient selection (44)
Peanut (23)
People (32595)
Peptides (25)
Pharmaceutical (22)
Pharmacy benefit managers (23)
Phase 1 (7633)
Phase 2 (9583)
Phase 3 (7243)
Pipeline (6527)
Policy (216)
Postmarket research (681)
Preclinical (3618)
Press Release (72)
Prostate cancer (171)
Psychedelics (28)
Radioligand (1)
Radiopharmaceuticals (210)
Rare diseases (479)
Real estate (3732)
Recruiting (21)
Regenerative medicine (14)
Regulatory (10271)
Reports (37)
Research institute (1530)
Resumes & cover letters (102)
Rett syndrome (10)
RNA editing (13)
RSV (28)
Saudi Arabia (1)
Schizophrenia (91)
Series A (160)
Series B (113)
Series C (1)
Service/supplier (10)
Sickle cell disease (54)
Special edition (14)
Spinal muscular atrophy (94)
Sponsored (32)
Startups (1815)
State (1)
Stem cells (4)
Substance use disorders (8)
Supply chain (90)
Switzerland (9)
Tariffs (28)
The Weekly (27)
Vaccines (401)
Venture capital (62)
Weight loss (133)
Wet AMD (5)
Women's health (72)
Worklife (9)
Date
Today (71)
Last 7 days (336)
Last 30 days (1647)
Last 365 days (13621)
2026 (12517)
2025 (13169)
2024 (16137)
2023 (18874)
2022 (26292)
2021 (27533)
2020 (27135)
2019 (25677)
2018 (19388)
2017 (14756)
2016 (14082)
2015 (15834)
2014 (11449)
2013 (9614)
2012 (10546)
2011 (11258)
2010 (10093)
Location
Africa (312)
Alabama (35)
Alaska (5)
Arizona (145)
Arkansas (12)
Asia (18039)
Australia (2602)
California (6853)
Canada (2781)
China (1036)
Colorado (400)
Connecticut (362)
Delaware (311)
Europe (44073)
Florida (934)
Georgia (213)
Hawaii (3)
Idaho (28)
Illinois (696)
India (67)
Indiana (515)
Iowa (13)
Japan (366)
Kansas (56)
Kentucky (44)
Louisiana (50)
Maine (38)
Maryland (1114)
Massachusetts (5359)
Michigan (205)
Minnesota (323)
Mississippi (4)
Missouri (123)
Montana (24)
Nebraska (16)
Nevada (73)
New Hampshire (31)
New Jersey (1761)
New Mexico (21)
New York (1746)
North Carolina (977)
North Dakota (10)
Northern California (3667)
Ohio (277)
Oklahoma (19)
Oregon (16)
Pennsylvania (1366)
Puerto Rico (24)
Rhode Island (33)
South America (479)
South Carolina (24)
South Dakota (1)
Southern California (2657)
Tennessee (144)
Texas (1148)
United States (25402)
Utah (161)
Vermont (2)
Virginia (151)
Washington D.C. (32)
Washington State (524)
West Virginia (4)
Wisconsin (109)
Wyoming (3)
330,372 Results for "alivamab discovery services".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
AlivaMab Biologics Announces Milestone- and Royalty-Free Access to AlivaMab(R) Mouse for Human Antibody Drug Discovery Services
September 3, 2025
·
2 min read
Press Releases
Ablexis Reports 33 AlivaMab(R) Mouse-Derived Human Antibodies Now in Clinical Development, Further Validating AlivaMab Mouse Transgenic Platform
March 4, 2026
·
2 min read
Press Releases
Sino Biological Launches 4RISE™ High-Throughput Wet-Lab Services to Accelerate AI-Driven Drug Discovery
November 13, 2026
·
3 min read
Press Releases
iSpecimen Expands Into AI-Powered Drug Discovery and Disease Trend Monitoring With Acquisition of Foldlab AI Products
New Agentic AI tools for protein discovery and disease trend prediction take iSpecimen beyond its biospecimen marketplace
November 5, 2026
·
6 min read
Press Releases
Chai Discovery Announces Collaboration with Roche in AI-Driven Drug Discovery
November 6, 2026
·
1 min read
Press Releases
Ablexis Announces Validation and Availability of AlivaMab(R) Mouse-NGX
September 3, 2025
·
1 min read
Business
Ablexis and AlivaMab Discovery Services Announce Expansion of Antibody Drug Discovery and Engineering Capabilities
Ablexis, LLC and AlivaMab Discovery Services, LLC announced an expansion of platforms and capabilities in antibody drug discovery and engineering.
November 15, 2022
·
4 min read
Business
AlivaMab Discovery Services Reappoints Dr. Larry Green as Chief Executive Officer
AlivaMab Discovery Services, a leader in the discovery of superior antibody-based therapeutics, announced that Larry Green has reassumed the role of Chief Executive Officer, effective immediately.
September 23, 2022
·
2 min read
Business
AlivaMab Discovery Services Expands Discovery Agreement with IGM Biosciences
AlivaMab Discovery Services, a leader in the discovery of superior antibody therapeutics, announced an expanded agreement with IGM Biosciences.
November 1, 2021
·
2 min read
Business
AlivaMab Discovery Services Appoints Jane Seagal, PhD, as Vice President of Antibody Discovery
AlivaMab Discovery Services, LLC, a leader in the discovery of superior antibody-based therapeutics, announced Jane Seagal, PhD, has joined the company as Vice President of Antibody Discovery.
January 11, 2022
·
3 min read
1 of 33,038
Next